Evidence map›Paper›PMID 30884312›Full record

ArticleiScience2019

PRISMA: Protein Interaction Screen on Peptide Matrix Reveals Interaction Footprints and Modifications- Dependent Interactome of Intrinsically Disordered C/EBPβ.

Gunnar Dittmar, Daniel Perez Hernandez, Elisabeth Kowenz-Leutz, Marieluise Kirchner, Günther Kahlert, Radoslaw Wesolowski, Katharina Baum, Maria Knoblich, Maria Hofstätter, Arnaud Muller and 3 more

Open access · goldAbstract read
In one paragraph

Article in iScience, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Protein Interaction Screen on a Peptide Matrix (PrISMa).Methods in molecular biology (Clifton, N.J.) · 2023
    Article
  15. Article
  16. Review
  17. Peptide array-based interactomics.Analytical and bioanalytical chemistry · 2021
    Article
  18. Article
  19. Peptide-based Interaction Proteomics.Molecular & cellular proteomics : MCP · 2020
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Gunnar DittmarProteome and Genome Research Laboratory, Luxembourg Institute of Health, 1a Rue Thomas Edison, 1445 Strassen, Luxembourg; Max Delbrück Center for Molecular Medicine, Robert-Roessle Strasse 10, 13125 Berlin, Germany; BIH Core Facility Proteomics, Robert-Roessle Strasse 10, 10125 Berlin, Germany. Electronic address: gunnar.dittmar@lih.lu.
Daniel Perez HernandezMax Delbrück Center for Molecular Medicine, Robert-Roessle Strasse 10, 13125 Berlin, Germany; BIH Core Facility Proteomics, Robert-Roessle Strasse 10, 10125 Berlin, Germany.
Elisabeth Kowenz-LeutzMax Delbrück Center for Molecular Medicine, Robert-Roessle Strasse 10, 13125 Berlin, Germany.
Marieluise KirchnerMax Delbrück Center for Molecular Medicine, Robert-Roessle Strasse 10, 13125 Berlin, Germany; BIH Core Facility Proteomics, Robert-Roessle Strasse 10, 10125 Berlin, Germany.
Günther KahlertMax Delbrück Center for Molecular Medicine, Robert-Roessle Strasse 10, 13125 Berlin, Germany.
Radoslaw WesolowskiMax Delbrück Center for Molecular Medicine, Robert-Roessle Strasse 10, 13125 Berlin, Germany.
Katharina BaumMax Delbrück Center for Molecular Medicine, Robert-Roessle Strasse 10, 13125 Berlin, Germany.
Maria KnoblichMax Delbrück Center for Molecular Medicine, Robert-Roessle Strasse 10, 13125 Berlin, Germany.
Maria HofstätterMax Delbrück Center for Molecular Medicine, Robert-Roessle Strasse 10, 13125 Berlin, Germany.
Arnaud MullerProteome and Genome Research Laboratory, Luxembourg Institute of Health, 1a Rue Thomas Edison, 1445 Strassen, Luxembourg.
Jana WolfMax Delbrück Center for Molecular Medicine, Robert-Roessle Strasse 10, 13125 Berlin, Germany.
Ulf ReimerJPT Peptide Technologies GmbH, Volmerstrasse 5, 12489 Berlin, Germany.
Achim LeutzMax Delbrück Center for Molecular Medicine, Robert-Roessle Strasse 10, 13125 Berlin, Germany; Humboldt-University of Berlin, Institute of Biology, 10115 Berlin, Germany. Electronic address: aleutz@mdc-berlin.de.
Max Delbrück Center · DEJPT Peptide Technologies (Germany) · DELuxembourg Institute of Health · LU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

CCAAT enhancer-binding protein beta (C/EBPβ) is a pioneer transcription factor that specifies cell differentiation. C/EBPβ is intrinsically unstructured, a molecular feature common to many proteins involved in signal processing and epigenetics. The structure of C/EBPβ differs depending on alternative translation initiation and multiple post-translational modifications (PTM). Mutation of distinct PTM sites in C/EBPβ alters protein interactions and cell differentiation, suggesting that a C/EBPβ PTM indexing code determines epigenetic outcomes. Herein, we systematically explored the interactome of C/EBPβ using an array technique based on spot-synthesized C/EBPβ-derived linear tiling peptides with and without PTM, combined with mass spectrometric proteomic analysis of protein interactions. We identified interaction footprints of ∼1,300 proteins in nuclear extracts, many with chromatin modifying, chromatin remodeling, and RNA processing functions. The results suggest that C/EBPβ acts as a multi-tasking molecular switchboard, integrating signal-dependent modifications and structural plasticity to orchestrate interactions with numerous protein complexes directing cell fate and function.

Indexed as

ProteomicsSystems BiologyTranscriptomics

Identifiers

PMID30884312
PMCPMC6424098
OpenAlexW2921921533

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.